Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05199584
Title A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Endeavor Biomedicines, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Los Angeles California 90095 United States Details
Research Site Santa Rosa California 95403 United States Details
Research Site Tampa Florida 33609 United States Details
Research Site Zion Illinois 60099 United States Details
Research Site Covington Louisiana 70433 United States Details
Research Site Las Vegas Nevada 89102 United States Details
Research Site New York New York 10065 United States Details
Research Site Durham North Carolina 27710 United States Details
Research Site Cincinnati Ohio 45229 United States Details
Research Site Columbus Ohio 43210 United States Details
Research Site Pittsburgh Pennsylvania 15232 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Fredericksburg Virginia 22408 United States Details
Research Site Lynchburg Virginia 24501 United States Details
Research Site Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field